| Autor: |
Wallace DS; Wilmot Cancer Institute and the Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA., Rowland C; TG Therapeutics, Inc, New York, NY, USA., Hill BT; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Baran AM; Department of Biostatistics and Computational Biology, University of Rochester, Rochester, NY, USA., Casulo C; Wilmot Cancer Institute and the Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA., Reagan PM; Wilmot Cancer Institute and the Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA., Winter A; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Karmali R; Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA., Winter JN; Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA., Gordon LI; Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA., Bui A; TG Therapeutics, Inc, New York, NY, USA., Sportelli P; TG Therapeutics, Inc, New York, NY, USA., Miskin HP; TG Therapeutics, Inc, New York, NY, USA., Weiss MS; TG Therapeutics, Inc, New York, NY, USA., Friedberg JW; Wilmot Cancer Institute and the Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA., Ma S; Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA., Barr PM; Wilmot Cancer Institute and the Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA. |
